Reported Sildenafil Side Effects in Pediatric Pulmonary Hypertension Patients

• Главные авторы: Stephanie Leigh Siehr (Автор), Elisa K McCarthy (Автор), Michelle T Ogawa (Автор), Jeffrey A Feinstein (Автор)
• Формат: ‌
• Опубликовано: Frontiers Media S.A., 2015-03-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

Background: Sildenafil, a phosphodiestase type 5 inhibitor, was approved in 2005 for the treatment of pulmonary arterial hypertension (PAH) in adults, and is commonly used off-label for pediatric patients. Little is known, however, about sildenafil's side effects in this population.Methods: Sin...